Japan To Cut Drug Prices By 10%

28 October 1997

Japan is to cut the prices of National Health Insurance-listed drugs byabout 10% next spring, in a move to reduce the budget deficit.

Announcing the price cuts, the third in consecutive years, the Ministry of Health and Welfare said a "substantial cut in drug prices" was central to curbing health spending growth and would reduce total drug spending in Japan by about 800 billion yen ($660 million) a year, saving the government 200 billion yen.

The MHW has just announced that health service spending went up a record 6% in 1996 to 26,420,000 billion yen ($21.78 billion), mainly as a result of a 9.7% rise in treatment costs for the over-70s.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight